Dual therapy (angiotensin‐converting‐enzyme inhibitors plus angiotensin receptor blockers) vs placebo or no treatment
Micro‐ to macroalbuminuria5 · people with diabetes and kidney disease
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes only0.1 [0.05, 0.24]1 study · 82 participantsLow